This is what he told Business of Cannabis about their education and training programme.
BofC – Graham, with demand for medical cannabis prescriptions on the rise in the UK, how crucial is clinician training in meeting this demand from a commercial standpoint?
Graham – We’ve developed a really comprehensive onboarding process that goes beyond cannabis training. It also includes standard training you’d expect in an NHS environment, such as safeguarding, protection of vulnerable adults, and even cybersecurity. We ensure that everyone who joins the organization—not just doctors—completes this training. We use a system called Blue Stream, which covers the mandatory training required by the CQC and our own internal standards.
Alongside this, we provide training on our bespoke patient portal. This is the platform clinicians use for assessments and follow-ups, and it’s where patients can access their prescriptions and other information.
We have a mix of about 26 doctors on our team, including some of the most experienced cannabis prescribers in the country, as well as newer doctors just beginning their journey with cannabis prescribing. It’s critical to have people who are genuinely interested in learning—not just about cannabis, but about the conditions it can treat. Some clinicians are deeply curious about the potential of cannabis, while others still view it with skepticism, even as something controversial.
Our training is very thorough, with approximately six modules that cover cannabinoids, minor cannabinoids, terpenes, sativas, indicas, CB1 and CB2 receptors, and much more. Some of our doctors have also completed external training programs, but we ensure consistency by having new clinicians shadow more experienced doctors. This helps them learn the assessment process, how to introduce cannabis as a therapy option, and adopt the ‘start low, go slow’ approach to prescribing.
BofC – How do you go about engaging ‘cannabis naive’ doctors?
Graham – We actively recruit new prescribers through various channels. On our website, we have a dedicated application page for those interested in prescribing. Additionally, we leverage LinkedIn, where we post opportunities and engage with our networks. At the start of the year, for example, we ran a LinkedIn campaign inviting interested doctors to reach out.
As part of our efforts, we organized two webinars, each attended by around 30 doctors or potential prescribers. These sessions included basic training and a Q&A segment. At the end of the webinars, we invited participants to contact us if they were interested in joining our team.
Read full interview at
